Results 161 to 170 of about 25,935 (265)

CAR-T cell therapy for pediatric solid tumors: armored CAR-T cells and beyond. [PDF]

Cancer Metastasis Rev
Wells J, Gupta A.
europepmc   +1 more source

End-of-Induction Response and Tolerability of High-Risk Neuroblastoma Treated with Chemoimmunotherapy-Modified N7 Regimen with Dinutuximab Beta. [PDF]

Cancers (Basel)
Lu ER, Hoo CPL, Cheung HM, Wong IWC, Fung KFK, Chang SLY, Lee ACW, Fu ECH, Ku DTL, Yau JPW, Shing MMK, Mak CYK, Liu APY, Chan GCF.   +13 more
europepmc   +1 more source

A comparative analysis of gamma and neutron radiation shielding properties of Gd₂O₃ nanoparticles within HDPE composites irradiated with argon ion beam. [PDF]

Sci Rep
Shabib M, Tawfik EK, Reheem AMA, Nada A, Ashry HA.   +4 more
europepmc   +1 more source

Orientationally Resolved Electron-Spin Relaxation and Coherence in Fullerene-Encapsulated Rare-Earth Dimers with a Single-Electron Metal-Metal Bond. [PDF]

J Am Chem Soc
Zalibera M, Spree L, Liu F, Rosenkranz M, Rapatskiy L, Schnegg A, Popov AA.   +6 more
europepmc   +1 more source

Combining Immunocytokine and Ex Vivo Activated NK Cells as a Platform for Enhancing Graft-Versus-Tumor Effects Against GD2+ Murine Neuroblastoma

, 2021
Paul D. Bates, Alexander L. Rakhmilevich, Monica M. Cho, Myriam N. Bouchlaka, Seema L. Rao, Joanna M. Hales, Rimas J. Orentas, Terry J. Fry, Stephen D. Gilles, Paul M. Sondel, Christian M. Capitini   +10 more
openalex   +1 more source

Anti-GD2 antibody 3F8 and barley-derived (1 → 3),(1 → 4)-β-D-glucan [PDF]

, 2013
Shakeel Modak, Brian H. Kushner, Kim Kramer, Andrew J. Vickers, Irene Y. Cheung, Nai‐Kong V. Cheung   +5 more
openalex   +1 more source

4SCAR-GD2-modified T-lymphocytes [PDF]

, 2020
openaire   +1 more source

B7-H3 and GD2 overexpression as immunotherapeutic targets in retinoblastoma. [PDF]

Sci Rep
Sujjitjoon J, Ng WL, Kongkla K, Jarutatsanangkoon K, Chongsutakawewong K, Subhadhirasakul S, Uiprasertkul M, Udompunturak S, Junking M, Yenchitsomanus PT, Atchaneeyasakul LO.   +10 more
europepmc   +1 more source

Concurrent naxitamab and lorlatinib in a patient with refractory high-risk neuroblastoma: a case report. [PDF]

Front Oncol
Aydin S, Oz A.
europepmc   +1 more source

The gamma delta T/NK cell product GADEKILL as a novel immunotherapeutic tool for neuroblastoma patients: role of B7H6 and BTN2A1 in tumor cell killing. [PDF]

Front Immunol
Morandi F, Della Lastra M, Pastorino F, Ciampi E, Faraci M, Brignole C, Giardino S, Airoldi I.   +7 more
europepmc   +1 more source